With recent advancements in molecular biology, it is now possible to uniquely identify specific genetic and molecular variations of a patient’s individual tumor. Known as a tumor profile, this profile can be used as the basis to formulate treatment plans that target the molecular structures that may be driving an individual patient’s unique cancer.
WHO: Chuck Gershman
WHEN: Founded in 2014
WHERE: San Jose, United States of America
RING EXPERIENCE: Pilot Contract Winner with HTXL - Philips
Privacy & Cookies Policy
Necessary cookies are absolutely essential for the website to function properly. This category only includes cookies that ensures basic functionalities and security features of the website. These cookies do not store any personal information.
Any cookies that may not be particularly necessary for the website to function and is used specifically to collect user personal data via analytics, ads, other embedded contents are termed as non-necessary cookies. It is mandatory to procure user consent prior to running these cookies on your website.